Showing papers in "Gastrointestinal Endoscopy in 2016"

TL;DR: Ruben D. Acosta as discussed by the authors, Neena S. Abraham, MD, MSCE, FASGE (invited content expert, ad-hoc member), Vinay Chandrasekhara, MD; Krishnavel V. Chathadi; Mouen A. Khashab; Shabana F. Pasha; and John R. DeWitt.

TL;DR: In this paper, a systematic review was conducted to evaluate the efficacy and safety of EUS-BD and to evaluate transduodenal (TD) and transgastric (TG) approaches.

TL;DR: EUS-guided drainage/debridement of WON using FCSEMSs and LAMSs is superior to DP stents in terms of overall treatment efficacy and on multivariable analysis, DP stent remains the sole negative predictor for successful resolution of Won.

TL;DR: In this paper, the authors evaluated clinical outcomes and safety of EUS-guided drainage of pancreatic pseudocysts and walled-off necrosis (WON) by using a novel lumen-apposing, fully covered, self-expandable metal stent.

TL;DR: SOC has become an integral part of the ERCP armamentarium and has high accuracy in the evaluation of indeterminate biliary strictures and achieving complete duct clearance in patients with biliary or pancreatic duct stones.

TL;DR: In this article, a real-time image recognition system was used to predict histologic diagnoses of colorectal lesions depicted on narrow-band imaging and to satisfy some problems with the PIVI recommendations.

TL;DR: In this article, the authors evaluated the long-term outcomes of EUS-guided injection of coils and CYA glue for therapy of gastric fundal varices (GFV).

TL;DR: The ASGE Technology Committee endorses using these advanced imaging modalities to guide targeted biopsies for the detection of dysplasia during surveillance of patients with previously nondysplastic BE, thereby replacing the currently used random biopsy protocols.

TL;DR: Patients with histologic IM or severe endoscopic atrophy were at increased risk of gastric cancer development after H pylori eradication.

TL;DR: Gastric cancer screening with endoscopy should be considered in individuals who are immigrants from regions associated with a high risk of gastric cancer (East Asia, Russia, or South America) or who have a family history of Gastric cancer.

TL;DR: FESD is a feasible, safe, and effective treatment for symptomatic ZD, with low adverse event and recurrence rates, including an in-depth evaluation of its efficacy, safety, and limitations.

TL;DR: In this article, the authors assess the accuracy of the American Gastroenterological Association (AGA) guidelines in detecting advanced neoplasia and present an alternative approach to pancreatic cysts.

TL;DR: In this paper, the feasibility of EUS-guided radiofrequency ablation (EUS-RFA) for managing patients with a symptomatic pancreatic neuroendocrine tumors by using a novel EUS needle electrode needle electrode was evaluated.

TL;DR: The 2016-17 NASPGHAN/FASGE Steering Committee is chaired by John M. DeWitt, MD, FASGE, who has previously served as chairman of the committee for three years.

TL;DR: The main objectives were to assess the histologic yield of the samples and compare the median number of passes required to obtain core tissue by using E US-FNB-SC and EUS-FNA needles.

TL;DR: NGS of pancreatic cyst fluid impacts clinical diagnosis and patient management by defining, supporting, or changing the clinical diagnosis based on imaging and CEA.

TL;DR: In this paper, the authors compared the diagnostic performance of using the current VLE scoring index (previously established as OCT-SI) and a novel VLE diagnostic algorithm (VLE-DA) for the detection of dysplasia.

TL;DR: In this paper, the authors compared EUS-guided pancreatic duct drainage (EUS-PDD) with e-ERP in terms of technical success (PDD through dilation/stent), clinical success (improvement/resolution of pancreatic-type symptoms), and AE rates in patients with post-Whipple anatomy.

TL;DR: The high success rates and good safety profile of remimazolam observed in this study warrants further investigation and confirmation in phase III trials.

TL;DR: In this article, the authors performed a systematic review and meta-analysis of studies to estimate an accurate recurrence risk after complete remission of IM through endoscopic therapy of Barrett's esophagus (BE) and high grade dysplasia (HGD)/esophageal adenocarcinoma (EAC).

TL;DR: The effect of surveillance, with focus on colonoscopy, on patient survival after CRC resection, the appropriate use and timing of Colonoscopy for perioperative clearing and for postoperative prevention of metachronous CRC, as well as the place of CT colonography and fecal tests in post-CRC surveillance are addressed.

TL;DR: Risk factors for PPB were identified that can help to guide management after gastric ESD, namely adjusting further management and second-look endoscopy is not associated with decreased PPB.

TL;DR: The efficacy of a simple traction method that uses dental floss and a hemoclip and was developed to overcome the technical difficulties of ESD is evaluated, finding ESD-DFC facilitated rapid ESD with good visualization and traction while ensuring high curability and safety.

TL;DR: Pancreatic tissues with at least 1 HPF were obtained by EUS-FNA from approximately 80% of patients, and nearly 60% of Patients were diagnosed with ICDC level 2 or higher.

TL;DR: In this article, the AIMS65 score was validated as a predictor of inpatient mortality in patients with acute UGIB and compared with established pre-and post-endoscopy risk scores.

TL;DR: In this article, the authors compared the tissue yield of EUS-guided Liver Biopsy (EUS-LB) and percutaneous (PC), transjugular (TJ), or surgical approach.

TL;DR: The data suggest that ER is a cost-effective strategy for removal of CCPs, driven by high technical success and low adverse event rates associated with ER, in addition to the increased cost of LR.

TL;DR: Patients with weight regain after RYGB should be evaluated for dilation of the gastrojejunal anastomosis, as TORe can be part of a multidisciplinary strategy to address post-RYGB weight regain.

TL;DR: The 2016-17 NASPGHAN/FASGE Steering Committee is chaired by John M. DeWitt, MD, FASGE, who has previously served as chairman of the committee for three years.